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Abstract
Background: The beneficial effects of human milk on decreasing rates of paediatric infections such as necrotizing
enterocolitis (NEC) and sepsis have been clearly demonstrated. Donor breastmilk has been encouraged as the milk
of choice when a mother’s own breastmilk is not available. The objectives of this study were to assess feasibility of
providing donor breastmilk to infants in a resource limited Neonatal Prem Unit (NPU). In addition we sought to
determine whether donor breastmilk could be safely pasteurized and administered to infants without any adverse
events.
Methods: Low birth weight infants < 1800 g and under 32 weeks gestational age were followed up in the NPU
over a 3 week period; feeding data and morbidity data was collected in order to determine if there were any
adverse events associated with donor breastmilk. Samples of pasteurized breastmilk were cultured to check for any
bacterial contamination.
Results: 191 infants met the inclusion criteria of whom 96 received their mother’s own breastmilk. Of the 95
infants who were potentially eligible to receive donor milk, only 40 did in fact receive donor milk. There was no
evidence of bacterial contamination in the samples analyzed, and no evidence of adverse events from feeding
with donor breastmilk.
Conclusion: It is feasible to supply donor breastmilk to infants in an NPU in a resource limited setting, however
staff needs to be sensitized to the importance of donor breastmilk to improve uptake rates. Secondly we showed
that it is possible to supply donor breastmilk according to established guidelines with no adverse events therefore
making it possible to prevent NEC and other side effects often associated with formula feeding of premature
infants.
Background
The particular benefits of human breastmilk for preterm
and term infants have been well described in medical
literature [1]. Human milk provides important nutri-
tional components, digestive enzymes, immunological
factors, growth factors, and hormones that make it a
clinical standard of care for preterm (including very
low-birth-weight) and term infants [2]. The beneficial
effects of human milk (fresh and pasteurized) on rates
of pediatric infection such as necrotizing enterocolitis
(NEC) and sepsis have also been clearly demonstrated
[3-5]. Donor breastmilk has been encouraged as the
milk of choice when a mother’s own breastmilk is not
available due to illness/infections, medications, or other
social reasons [6]. Using human milk is of particular
importance for preterm infants of HIV infected mothers
as early introduction of formula feeds could be the
source of allergens or contaminants. These allergens/
contaminants in such an immature infant could provoke
gut epithelial damage and therefore put the child at
increased risk of breastfeeding transmission [7-9] once
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breastfeeding commences. Research from the United
States indicates that even if donor milk is only half as
effective as mothers’ own milk in reducing infection and
NEC in newborn infants, providing donated pasteurized
breastmilk in a neonatal clinical setting is still more
cost-effective than relying on preterm formula [10].
Because of the well documented benefits of donor
breastmilk, a donor breastmilk bank was set up in the
Neonatal Prem unit (NPU) of King Edward VIII Hospi-
tal (KEH) in Durban, South Africa at the beginning of
2009. KEH is a public hospital that serves a disadvan-
taged community and its NPU has an average intake of
180 infants per month. As part of the routine protocol
in the NPU all mothers of HIV unexposed infants are
encouraged to provide breastmilk to their infants. HIV
infected mothers are routinely counseled on appropriate
infant feeding for their situation according to WHO
guidelines. HIV infected women who opt to breastfeed
are taught how to heat treat their own expressed breast-
milk (HTEBM) before they feed it to their infants. The
new breastmilk bank that was opened a few months
prior to the commencement of this evaluation study
operates under the guidelines of the Human Milk Bank-
ing Association of South Africa (HMBASA) [11]. As it is
unlikely that there will ever be an unlimited supply of
donor milk, each child is assessed for their eligibility to
receive donor milk. Preterm/low birth weight infants
whose mothers are not able to supply their own milk
are eligible to receive donor breastmilk if they are HIV
infected and/or if they are at risk of NEC. The duration
of donor breastmilk given to an infant depends firstly
on the availability of donor breastmilk supplies and sec-
ondly, on the child’s condition as assessed by the NPU
doctor in charge. Donor mothers are sourced from the
NPU and obstetric wards of KEH and they are healthy,
HIV negative women (determined on 2 separate HIV
tests) who are screened for absence of any lifestyle risks.
All donor mothers in the unit use hand expression to
express breastmilk into a 250 ml sterile glass jar which
is then pasteurized by a breastmilk bank assistant,
rapidly cooled and then decanted into a smaller sterile
glass jar for storing. Following HMBASA guidelines,
post-pasteurisation, an aliquot of milk is removed from
the first donation of each new donor and is tested for
microbial contamination. Each donor is given a donor
number which is recorded on the bottle of milk together
with the date of expression. Donor breastmilk is kept
frozen in a -20°C chest freezer for up to 3 months after
expression. Because the concept of donation of breast-
milk was new in the hospital, when there were periods
of insufficient supplies the breastmilk bank also sourced
pasteurized donor breastmilk from a nearby NGO run
community based breastmilk bank. This NGO run milk
bank uses the same donor screening and bacterial
screening practices, the only difference is that the milk
is pasteurized by the Holder Pasteurisation Method
using an automated commercial pasteurizer (Sterifeed
S90).
Implementing a milk bank in this resource-poor set-
ting presented multiple challenges particularly because
of inadequate staffing and lack of funds for maintenance
of equipment. Therefore a decision was made to use a
method of pasteurization that would be more appropri-
ate within these limitations. This pasteurization method,
known as flash-heat, is a simple method which involves
heating individual jars of breastmilk in a water bath.
Flash-heat mimics commercial high-temperature short-
time (HTST) pasteurization. This ‘low-tech’ method of
pasteurization, has been documented to inactivate cell-
free [12] and cell-associated HIV [13]; destroy patho-
genic and non-pathogenic bacteria [14] and preserves
the vast majority of vitamins [15], immunoreactive pro-
teins and immunoglobulins [16].
There is skepticism among health care workers and
policy makers in South Africa around feasibility and
safety of human milk banks in this area mainly because
of the fear of HIV transmission and the cultural accept-
ability. These concerns have severely hampered the use
of donor breastmilk and there is therefore an urgent
need for this information from South Africa to clarify
these issues. This study hopes to provide some of this
information which is in keeping with a resolution passed
during the 61st World Health Assembly Meeting in
Geneva (May 2008) calling on the World Health Orga-
nization to support countries to conduct research on
the feasibility of implementing breastmilk banks. There
have been no prospective studies in South Africa exam-
ining the feasibility or safety of donor breastmilk sup-
plied by breastmilk banks in NPUs. However there has
been a report of anecdotal data suggesting that it was
feasible and safe to provide donor breastmilk to infants
during an outbreak of rotavirus [17].
The objectives of this study were twofold. First, we
sought to address feasibility by documenting whether
the medical staff would prescribe donor milk for infants;
and whether eligible mothers in the unit would be pre-
pared to donate breastmilk to the bank. We also investi-
gated the feasibility of adhering to the HMBASA quality
assurance guidelines for microbial testing of breastmilk.
Secondly we sought to evaluate an aspect of the safety
of providing donor milk by documenting clinical adverse
events of infants fed on donor milk compared to for-
mula milk. We did not seek to investigate whether
infants fed on donor milk had a better outcome than
those fed on formula milk as this has already been
established as concluded in a Cochrane Review [5].
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Methods
Study site, population and design
The study was an observational longitudinal cohort study.
Mothers with low birth weight infants were recruited to
participate in this study. The study population consisted of
Low birth weight infants < 1800 g and under 32 weeks
gestational age who were admitted to the NPU at KEH dur-
ing the 6 month period June 2009 to December 2009. We
selected 1800 g as an upper weight limit since larger babies
were more likely to have abbreviated hospital stays and thus
insufficient days for observation. We also particularly
focused on infants < 1800 g and < than 32 weeks gestational
age as they are at particular risk of developing NEC and
other problems associated with formula feeds. Exclusion
criteria included infants whose hospital stay was less than 3
days; infants with congenital abnormalities and infants who
were only admitted to the unit > 24 hours after birth.
Infants whose mothers were not able or willing to sign writ-
ten informed consent were also not eligible for the study.
Data collection methods and tools
Enrolment data was collected from the peripartum his-
tory and maternal medical history recorded in the hos-
pital charts. During the infant’s hospital stay morbidity
and feeding data was collected. Frequency of neonatal
complications during a 3 week observation period were
recorded after clinical examination by the study doctor
(IC) and from perusal of the clinical records. Infection
was documented by the presence of clinical and labora-
tory signs of a systemic inflammatory response and/or
positive cultures for pathogenic organisms at one or
more of the following sites: blood, spinal fluid, urine,
stool, respiratory secretions, umbilicus, or surgical
wound. The morbidity was analyzed according to receipt
of any donor milk vs receipt of formula milk only.
Methodology for microbiology
An aliquot of 5 mls was removed from the first sample
of pasteurized expressed breastmilk from each donor
and was kept frozen at -20°C until it was analyzed.
Frozen samples were transported in batches to the
National Health Laboratory Services at Inkosi Albert
Luthuli Hospital, Durban. The methodology involved
plating a 100 μl of the pasteurized milk sample onto
MacConkey agar which was incubated for 24 hrs at 37°C.
The following day a semi-quantitative count was per-
formed. If any suspicious colonies were observed they
were identified further.
Statistical considerations
The study was analyzed using SPSS 15.0 (© SPSS Inc.).
Continuous variables were checked for normality of dis-
tribution and means/standard deviations (SD) are
reported for the normally distributed variables and
medians/inter-quartile ranges for the skewed variables.
Counts and observed percentages are reported for the
categorical data. Chi squared tests were used to compare
the characteristics and complications present in the
infants who received donor breastmilk and/or formula
feeds.
Ethical review
The study protocol was approved by the Biomedical
Ethics Committee, University of KwaZulu Natal (ref: BE
176/08) and the King Edward V111th Hospital
Authorities.
Written informed consent was obtained from mothers
for their infants’ clinical records to be used in the study.
Results
During the study period June to November 2009, a total
of 191 infants met the inclusion criteria and were
enrolled into the study. The baseline characteristics of
the 191 mother/infant pairs who were enrolled in the
study are shown in table 1. The mean duration of hospi-
tal stay ranged from 3 to 72 days and 83 infants (43.5%)
actually had a hospital day of less than 3 weeks which
was the expected period of study observation. Of the
191 infants, 96 received their mother’s own breastmilk
so potentially 95 infants were eligible to receive donor
milk as a first feed. Only 16 received donor milk and
the remaining 79 infants received formula milk as the
first feed. However of the 79 infants who were started
on formula milk a further 24 infants were changed to
donor milk. Therefore of 95 infants who were
Table 1 Characteristics of the mothers and infants
(n = 191)
Parameter
Maternal age (years): Mean (SD) 26.51 (6.07)
Maternal positive HIV status: number (%) 100 (52.4)
Twin delivery: number (%) 43 (22.5)
Current or treated TB: number (%) 10 (5.24)
Current or treated Syphilis: number (%) 6 (3.1)
Peripartum complications: number (%) 169 (88.48)
Caesarean delivery: number (%) 99 (51.8)
Gestational age (weeks): Median (IQR) 32 (30-33)
Small for gestational age infant: number (%) 61 (31.9)
Infant birth weight (kg): Mean (SD) 1.38 (0.26)
Duration of hospitalisation Median (IQR) 22 (13-30)
First feed used: Formula: number (%) 79 (41.4)
Breastfeed: number (%) 81 (42.4)
HTEBM: number (%) 15 (7.9)
Donor breastmilk: number (%) 16 (8.4)
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potentially eligible to receive donor milk only 40 did in
fact receive donor milk. In only one case was the reason
due to mother refusing donor milk, in all the other
cases it had not been offered as an option to the
mother. The reasons for prescribing donor milk for
these 40 infants is shown in table 2.
In terms of adverse events/clinical outcome, as can be
seen in table 3, there were no differences in prevalence
of neonatal complications in those infants who received
any donor breastmilk vs. those who received only for-
mula milk. Because of limitations in terms of a wide
variation in the risk profile; and duration and type of
feeds it is difficult to do these types of comparisons and
we therefore also decided to capture details of individual
case histories of some of the infants who received donor
breastmilk in order to better capture the safety of donor
breastmilk. Two of these are presented in summary
form:
Infant A was born at 32 weeks gestation (birth weight:
1.7 kg) to a 33 year old HIV negative, para 3 mother
following a caesarian section for severe pre-eclampsia.
Mother had left arm paralysis since adolescence follow-
ing a head injury. She had chosen to breastfeed antena-
tally, however the nurses decided as she had a paralytic
arm, she would be unable to hold her baby and started
her baby on formula. NEC developed on day 2 following
formula feeds (abdominal distension; feed intolerance;
severe umbilical flare; dilated visible bowel loops; and
pneumatoses on abdominal X-ray). Feeds were discontin-
ued for 2 days, following which breastfeeding was
initiated by the mother supported by the study doctor.
Donor milk was given for four days while the mother’s
milk was coming down. NEC resolved after 6 days on
treatment. Baby was doing well and discharged on
breastfeeds and expressed breastmilk top-ups, 4 days
after resolution of NEC.
Infant B was born at 29 weeks gestation (birth weight
1.1 kg) to a 41 yr old HIV negative, para 4 mother, with
previous breast cancer and therefore not planning to
breastfeed. Infant received formula milk feeds for the first
3 weeks of life and developed NEC (abdominal disten-
sion, vomiting, bloody stools and thickened bowel wall on
abdominal X-Ray). He was taken off feeds for 5 days and
then commenced on donor breastmilk for a further 3
weeks until discharge. Did extremely well on donor
breastmilk and showed marked clinical improvement. In
fact during the period of receiving donor breast milk the
nursing staff attempted re-introducing formula feeds but
these were not tolerated at all and were accompanied by
projectile vomiting so were discontinued and donor
breastmilk re-introduced.
We were successful in obtaining donors from amongst
the mothers who were in hospital usually waiting for
their infants to gain weight or get better. During the 6
month period of study we were able to recruit 35 donors.
Because the concept of donation of breastmilk was new
in the hospital when there were periods of insufficient
supplies the breastmilk bank also sourced breastmilk
from a nearby, NGO run, community based breastmilk
bank. It was estimated that during the first 12 months
of operation approximately 20% of the supplies were
externally sourced whereas in the last 12 months
(Jan 2010 to December 2010) the bank is operating
completely on in-house donations of breastmilk.
Of the 35 in-house donors, 30 of the samples were
analyzed for presence of bacterial contamination, post-
pasteurization (flash heating). No bacterial contamina-
tion was found in any of the 30 samples analyzed.
Discussion
This evaluation has shown that donor milk was in fact
prescribed for 40 of the potentially 95 eligible infants.
There were obvious missed opportunities which were
due to medical staff not discussing with mothers that
there was donor breastmilk available and that this was
an option. We did not evaluate in each case why donor
breastmilk was not prescribed when it was indicated but
anecdotal evidence suggests that there were 2 main
reasons. First, at the time of the study, where there was
no routine nevirapine prophylaxis during breastfeeding,
the standard NPU protocol was to prescribe preterm
formula for HIV exposed infants whose mothers had
either chosen to formula feed or who had chosen to
breastfeed but were unable to provide the necessary
milk. Second, because donor breastmilk was a very new
option in the unit and because of the rotation of medi-
cal staff through the unit it takes a while to train all the
staff and gain acceptance for donor breastmilk. Addi-
tionally it is easier and less time consuming for nurses
and doctors to prescribe formula feeds compared to
donor milk and the formula feeds are easier to access
compared to the donor milk. In effect 42% of the eligi-
ble infants had donor breastmilk prescribed for them
which we believe is an acceptable percentage for such a
new concept. While this evaluation study was being
conducted a separate acceptability study was also
Table 2 Reasons for use of any donor breastmilk (n = 40)
Reason Frequency
Insufficient breastmilk* 27 (67.5)
Twins 1(2.5)
Not tolerating formula 3 (7.5)
Sick infant 1(2.5)
Mum sick/unable to breastfeed 4 (10.0)
Re-feeding after NEC related to formula 1(2.5)
Post c/s 3 (7.5)
* According to mother and/or nursing staff
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conducted in the unit. Results of this study showed that
there were indeed concerns and lack of understanding
around donor breastmilk which participants felt could
be overcome with education and dissemination of infor-
mation [18]. In response to the findings of the accept-
ability study the unit developed educational materials
and resources and conducted educational sessions
around donor breastmilk banking. Recent anecdotal data
suggests that this education has resulted in the medical
team being more convinced of the safety of donor
breastmilk and more infants are now being offered
donor breastmilk.
This evaluation has also shown that it is possible to
supply donor breastmilk in neonatal prem units in
resource poor settings with no adverse events experi-
enced by the infants, therefore making it possible to pre-
vent the NEC and other side effects often associated
with formula feeding of premature infants. This also has
important implications in terms of protecting and pro-
moting breastfeeding and has the potential to play a role
in decreasing infant mortality rate as has been shown in
a country like Brazil which has reported dramatic
decreases in its under-five mortality rate following the
growth in donor breastmilk banking [19]. There are
other obvious benefits of being able to supply donor
breastmilk in settings with high HIV prevalence as the
new WHO guidelines encourage breastfeeding by HIV
infected women while the infants receive nevirapine
prophylaxis [20]. There were obvious limitations to the
study. Firstly the amount of time spent in hospital by
each infant was variable so we tried to compensate for
this by taking a set period of time which we felt would
cover the majority of the infants viz. 3 weeks. However
not all infants stayed in the unit for the full 3 weeks -
83 (43.5%) stayed for less than 3 weeks. An additional
limitation of the study was that because we could not
control the type of feeds each infant received; each
infant may have received a variety of feeds, for example
if mother is able to express a small amount of breast-
milk which is insufficient for a full day’s feed, the infant
on that day may receive mother’s own milk in addition
to donor breastmilk. We were also unable to assess for
differences between the infants who received formula
only and those who received donor breastmilk only as
the number of infants who received the donor breast-
milk was small. Additionally we were not able to elimi-
nate the strong possibility of reverse causality as
neonatal complications often preceded and were the rea-
son for the receipt of donor breastmilk. This was a sig-
nificant limitation of the study and this could only have
been assessed appropriately in a randomized controlled
trial which would have been unethical.
Finally, although the small number of samples that
were assayed showed no bacteriological contamination it
Table 3 Prevalence of neonatal complications and characteristics amongst the infants who received donor breastmilk
and/or formula milk for > 24 hours (n = 106)
Complications (% within each type of feed) Type of feeds received
Formula (n = 66) Donor breastmilk (n = 18) Both formula and donor (n = 22)
Neonatal sepsis 61(92.4) 18(100) 20 (90.9)
Neonatal jaundice 54 (81.8) 15 (83.3) 20 (90.9)
NEC 10 (15.2) 2 (11.1) 5(22.7)
Abdominal distension 22 (33.3) 7 (38.9) 7 (31.8)
Feeds intolerance 15 (22.7) 2 (11.1) 7 (31.8)
Hypoglycemia 1 (1.5) 0 (0) 1 (4.5)
Pneumonia 5 (7.6) 2 (11.1) 2 (9.1)
Severe respiratory distress requiring CPAP or IPPV 20 (30.3) 8 (44.4) 7 (31.8)
Seizures 3(4.5) 1(5.6) 1(4.5)
Meningitis 1(1.5) 0 (0) 2 (9.1)
Nosocomial sepsis 35 (53) 11(61.1) 20 (90.9)
Severe anaemia requiring transfusion 20 (30.3) 6 (33.3) 10 (45.4)
Broncho-pulmonary dysplasia (BPD) 8 (12.1) 4 (22.2) 4 (18.2)
IVH 6 (9.1) 0 (0) 6 (27.3)
Superficial infections 15 (22.7) 4 (22.2) 6 (27.3)
Congenital syphilis 1 (1.5) 0 (0) 1 (4.5)
Duration of hospitalization (days): Median (Range) 22 (5-71) 16.5 (6-44) 25 (11-72)






*p values were not significant (< 0.05) for the differences between the three groups
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is possible that with a much larger number of samples
we would have detected some samples with bacterial
contamination as was shown recently in an analysis
from breastmilk banks in the US [21]. In particular
breastmilk banks have shown concern that during the
heating process there may be increased growth of Bacil-
lus sp. [22]. However, while spore-forming Bacillus sp.
may survive pasteurization, unlike cow’s milk this is
thought to be a rare contaminant of human breast milk
[23]. Regardless, this type of contamination can be con-
trolled by proper storage and handling after pasteurisa-
tion, which should prevent any Bacillus species that are
present from growing. Some of these safeguards include,
pasteurizing the milk as soon as possible after expres-
sion and then storing the sample frozen which will elim-
inate the majority of bacteria and thus avoid extensive
growth of Bacillus during storage. Additionally pasteur-
ized samples should remain covered and the lids should
not be removed until feeding. It is also important to
note that although Bacillus sp. may be a contaminant in
food and dairy sources when it is present in breastmilk
this danger is considerably attenuated because the med-
ium of breastmilk unlike that of other food and dairy
sources contains important factors that minimize bacter-
ial growth. Furthermore it is important to balance the
benefits of providing donor milk compared to the alter-
native of infant formula which has also been shown to
be prone to contamination even with Bacillus sp [24].
We acknowledge that further investigation into cost-
effective and simplified donor milk screening is war-
ranted to allow for testing of each sample specifically for
Bacillus sp., especially for low-cost settings desiring to
utilize a simple method of pasteurization such as Flash-
heat described here. However the current process of cul-
ture methods would be cost-prohibitive in resource poor
settings. A methodology that may be more applicable in
resource poor settings may be the system employed in
the Brazilian banks in which a pH test is utilized to iden-
tify potential bacterial contamination [25]. We recom-
mend that research is needed to develop a simplified
low-tech tool to detect bacterial contamination such as a
dipstick rapid diagnostic test. This would have important
benefits for developing affordable quality assurance sys-
tems for breastmilk banks in resource limited settings.
Conclusion
This study has shown firstly that it is feasible to access
mothers who are prepared to dnate breastmilk and it is
feasible for infants to receive donated breastmilk. Secondly
we have shown that it is possible to supply donor breast-
milk according to established guidelines in NPUs in
resource poor settings with no adverse events, therefore
making it possible to prevent NEC and other side effects
often associated with formula feeding of premature
infants. We believe this low-tech system of breastmilk
banking can be reproduced in similar settings and would
recommend that for successful scale-up, the endorsement
and involvement of the Ministry of Health is essential as
has been seen in the Brazilian system of breastmilk bank-
ing. Furthermore we recommend that low income coun-
tries should follow the Brazilian model of having a
comprehensive, integrated breastfeeding promotion strat-
egy including donor breastmilk banking with the ultimate
aim of improving child survival. In South Africa especially,
scale up of donor breastmilk banks would have a profound
impact on breastfeeding promotion which is vital in order
to improve infant survival rates. Furthermore this would
assist to reverse current predictions that South Africa is
unlikely to meet the millennium development goal 4 [26].
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